Prevention of hepatitis C virus infection in haemophiliacs.
D001782:Blood Donors; D002648:Child; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006526:Hepatitis C / Q000517:prevention & control* / Q000635:transmission; D006525:Hepatitis, Viral, Human / Q000517:prevention & control*; D006358:Hot Temperature; D006801:Humans; D014842:von Willebrand Diseases / Q000628:therapy
D005169:Factor VIII